Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FWHE0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,272
Award facts
- Contract value 100% obligated
- $17,271.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 7, 2026, by the Defense Logistics Agency for the supply of Orencia ClickJect 125 mg/ml, a biologic immunosuppressant medication used primarily for rheumatoid arthritis treatment. This firm fixed-price delivery order, valued at $17,271.84, represents a non-set-aside, competitively awarded contract with an ultimate completion date of January 8, 2026. The order will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen's role as a pharmaceutical prime vendor for the Defense Logistics Agency underscores its critical importance to federal medical procurement operations. The company's IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, enabling efficient distribution to Defense Health Agency facilities, military treatment centers, and other government healthcare systems. The company's demonstrated capability to manage both large-value indefinite contracts and individual delivery orders reflects its established position as a key supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FWHE0?
SPE2DR26FWHE0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FWHE0 worth?
The government has obligated $17,272 on SPE2DR26FWHE0.
Is contract SPE2DR26FWHE0 an order under another contract?
Yes. SPE2DR26FWHE0 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHE0 competed?
The extent of competition for SPE2DR26FWHE0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award